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The hexapeptide WRWYCR was previously identified on the basis of its ability to inhibit bacteriophage
lambda integrase-mediated recombination by trapping and preventing resolution of the Holliday junction
intermediate. This peptide inhibits several unrelated DNA repair enzymes that bind to and process Holliday
junctions and branched DNA substrates. WRWYCR and its D stereoisomer, wrwycr, are bactericidal against
both Gram-positive and Gram-negative bacteria, causing the accumulation of DNA breaks, chromosome
segregation defects, and the filamentation of cells. DNA repair is a novel target of antibiotics. In the present
study, we examined the ability of the peptides to inhibit the growth of Salmonella in mammalian cells. J774A.1
macrophage-like cells and murine peritoneal macrophages were infected with Salmonella enterica serovar
Typhimurium and grown in the presence or absence of peptide. We found that peptide wrwycr reduced the
number of Salmonella cells recovered after 24 h growth in J774A.1 cells by 100 to 1,000 times, depending on the
multiplicity of infection. The peptide also inhibited Salmonella growth in peritoneal macrophages, and although
higher doses were required, these were not toxic to the host cells. The apparent lower level of potency of the
peptide paralleled the lower level of replication of Salmonella and the lower level of permeation of the peptide
in the peritoneal macrophages than in the J774.1 cells. Treatment with peptide wrwycr elicited the SOS
response in a significant fraction of the intracellular bacteria, as would be expected if the mechanism of
bacterial killing was the same in pure culture and in host cells. These results represent a proof of principle of
the antimicrobial activities of compounds that target DNA repair.
The hexapeptide WRWYCR was previously identified on
the basis of its ability to inhibit bacteriophage lambda integrase
(Int)-mediated site-specific recombination by accumulating the
Holliday junction (HJ) intermediates during the reaction (4).
Holliday junctions are also central intermediates in homolo-
gous recombination-dependent DNA repair, which often but
not exclusively involves RecA-dependent strand invasion. The
double-strand breaks that are generated by oxidative damage,
irradiation, or interstrand cross-links or nicks that have been
converted to double-strand breaks during replication require
repair of the break by use of the homology on the sister chro-
mosome (14, 15, 28). During the repair process, chromosome
dimers may arise. Such dimeric chromosomes cannot be prop-
erly segregated to daughter cells, unless they are converted to
monomers by the Int-related bacterial site-specific recombi-
nases XerC and XerD, which also generate Holliday junction
intermediates during recombination at dif sites (3). These pro-
cesses are extremely important, if not essential; for example,
up to 50% of recA mutant cells are nonviable, and the remain-
der are hypersensitive to any DNA damage (14). Although
mutations in XerC and/or XerD are not lethal, they are detri-
mental to cell growth, particularly under conditions that cause
DNA damage (32). DNA repair has been inferred to be ex-
tremely important for the survival of Salmonella during infec-
tions, on the basis of the finding that recA and recBC mutants
are avirulent (they have a more than 4-log-unit greater 50%
lethal dose in mice than Rec strains) and that Salmonella
isolates growing within macrophages incur a variety of DNA
lesions, including DNA breaks (8, 9, 30). Peptide WRWYCR
may thus inhibit bacterial growth, particularly under physio-
logical conditions in which DNA repair is necessary.
Peptides WRWYCR and its D stereoisomer, wrwycr, do not
require contact with proteins but, rather, are structure selective
for branched DNAs. As they are dimers via a disulfide bridge,
they recognize and bind to four-arm (Holliday) junctions (Kd,
12 to 14 nM) and bind with a reduced affinity and lesser
stability to three-arm DNA structures that mimic replication
forks (Kd, 64 to 132 nM) (25, 26; J. Boldt, R. Saha, J. Arciniega,
and A. M. Segall, unpublished results). This enables the pep-
tides to inhibit a number of structurally and mechanistically
unrelated proteins that process HJs, D loops, and related DNA
intermediates of DNA repair (10, 22, 25, 26).
Both WRWYCR and wrwycr inhibit bacterial growth in a
dose-dependent manner, with wrwycr showing greater potency
at longer incubation times, presumably due to its resistance to
proteases. MIC assays showed that Gram-negative bacteria
(Escherichia coli, Salmonella) were less sensitive to the peptide
(64 M) than Gram-positive bacteria (Bacillus subtilis, Lacto-
coccus lactis, Listeria monocytogenes, Staphylococcus aureus,
methicillin-resistant S. aureus) and Gram-negative bacteria
with mutationally shortened lipopolysaccharide (LPS) chains
(8 to 32 M), while viability assays revealed that the peptides
are bactericidal at 1 to 2MICs (22). More recently, Debora
Barnett Foster’s laboratory showed that the peptide has activ-
ity against a number of clinical E. coli strains in vitro (M. Lino,
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Z. Naqvi, S. D. Goodman, A. M. Segall, and D. Barnett Foster,
unpublished data).
Peptide wrwycr and its close relatives stabilize HJ interme-
diates of phage lambda site-specific recombination in E. coli
and inhibit the tyrosine recombinase-dependent excision of
prophages in both E. coli and Salmonella enterica LT2 (23).
Treatment of E. coli with the peptide also resulted in the
accumulation of filamentous cells and a 10-fold increase in
anucleate cells, suggesting that the loss of bacterial viability
was due to the combined effects of DNA breaks and chromo-
some segregation defects (22). However, while XerCD-depen-
dent recombination in vitro is inhibited by wrwycr with a 50%
inhibitory concentration of 50 nM, mutants with neither a
single nor a double xerC and xerD mutation were resistant to
the peptide. The dose of peptide treatment was positively cor-
related with the fraction of cells with fragmented DNA, mea-
sured either by fluorescently labeling the free 3 OH DNA
ends inside the bacteria (22) or by directly visualizing double-
strand breaks by pulsed-field gel electrophoresis (C. W. Gun-
derson and A. M. Segall, unpublished data). The cumulative
effect of the DNA damage resulting from peptide treatment
induced the SOS response (22).
The idea of using antimicrobial peptides (AMPs) as antibi-
otics is not new. Naturally occurring AMPs are extremely
abundant and diverse. They are found in most organisms, from
insects to humans and plants, as well as some bacteria and
fungi, and are part of the innate immunity system (5, 7, 35, 38).
Many of these peptides kill by forming pores in the bacterial
membrane, such as melittin (27), defensins (37), and cecropin
(12). Other peptides, such as mersacidin, inhibit peptidoglycan
synthesis (6). Still others have intracellular targets (5, 38).
Moreover, several peptide-based drugs are being developed
for clinical use.
Peptide wrwycr is the first antibiotic to date to inhibit DNA
repair, which is a novel target of antimicrobial action (22). In
the face of the ever growing number of antibiotic-resistant
bacteria, the antibacterial properties of our peptides, which
target DNA repair, a novel target of antimicrobial action,
merit further investigation. In the study described here, we
showed that peptide wrwycr inhibits the growth of Salmonella
inside macrophage-like cells and murine peritoneal macro-
phages. Treatment with the peptide induces the SOS response
in a significant fraction of the bacteria growing inside macro-
phages. These results suggest that the peptide may be worth
exploring as the lead compound in a new class of antimicrobial
compounds.
MATERIALS AND METHODS
Salmonella enterica serovar Typhimurium strains. The virulent ATCC 14028S
strain of Salmonella enterica serovar Typhimurium (Segall laboratory designa-
tion, strain G488) was obtained from Ferric Fang via Stanley Maloy. Strain
SDT1416 was constructed by transformation of strain G488 with plasmid
pFPV25.1, which encodes a constitutively expressed, bacterium-adapted high-
level-fluorescence green fluorescent protein (GFP) driven by the rRNA (rrn)
promoter (36). The MIC of wrwycr against SDT1416 was determined, according
to the NCCLS protocol for broth microdilutions, to be 64 M (19, 22). Strain
G785 [ATCC 14028S (sulA-lacZY)111] carries a chromosomal copy of the
lacZ gene driven by the sulA promoter in an otherwise SulA-positive (SulA)
background (the construct was the generous gift of James Slauch, University of
Illinois). Unless otherwise specified, all media were purchased from Fisher Sci-
entific, Pittsburgh, PA.
Mammalian cells. The murine macrophage-like cell line J774A.1 was grown in
Dulbecco modified Eagle medium (DMEM; Invitrogen, Carlsbad, CA) supple-
mented with 10% heat-inactivated fetal bovine serum (FBS; BioWhittaker,
Walkersville, MD) at 37°C with 5% CO2. The cells were grown in 75-cm2 flasks
(Corning Inc., Corning, NY) with vented caps and passaged when the cell density
reached80%. To passage the cells, the medium was removed and the cells were
washed with 10 ml of 1 mM EDTA dissolved in 1 phosphate-buffered saline
(PBS). The cells were incubated with a trypsin solution (0.5% trypsin with 0.2
mM EDTA in 1 PBS) for 10 min at 37°C with 5% CO2 to release them from
the tissue culture flask. Unless otherwise specified, all chemicals were purchased
from Sigma-Aldrich, St. Louis, MO, or Fisher Scientific.
To harvest peritoneal murine macrophages, 8- to 12-week-old female BALB/c
mice were injected in the peritoneal cavity with 1 ml of 4% thioglycolate to
induce macrophage proliferation and were killed 4 days later. The thioglycolate
solution was prepared by dissolving thioglycolate powder in boiling water, and
the mixture was then autoclaved. Peritoneal macrophages were harvested by
washing the peritoneal space with 10 ml of DMEM (without FBS) and collecting
the effluent. The cells were centrifuged for 5 min at 4°C (Sorvall RT6000 cen-
trifuge) at 700 rpm and were then resuspended in DMEM–10% FBS with
penicillin and streptomycin (Invitrogen). The cells were counted with a hemo-
cytometer and plated at the appropriate densities. All relevant federal guidelines
and institutional policies concerning the use and handling of animals were strictly
followed.
Peptide uptake. (i) Localization by microscopy. J774A.1 cells or peritoneal
macrophages were seeded in four-well (LabTek-II; Fisher Scientific, Pittsburgh,
PA) chamber slides at 200,000 cells per well and the slides were incubated at
37°C in 5% CO2 overnight to allow adhesion. The medium was removed and
replaced with fresh DMEM containing N-terminal rhodamine (Rh)-labeled pep-
tides (Sigma-Genosys, St. Louis, MO), and the slides were incubated for the
indicated length of time. The medium was removed after incubation, and the
cells were washed three times with 1 PBS and then fixed with 4% paraformal-
dehyde for 30 min. After removal of the paraformaldehyde and washing of the
cells once more with 1 PBS, the chambers were detached from the slide. The
slide was inverted onto a coverslip with the SlowFade reagent (Invitrogen Mo-
lecular Probes, Carlsbad, CA), added to minimize photobleaching. Series of
images were collected with a TCS SP2 confocal microscope (Leica Microsystems
Inc., Bannockburn, IL).
(ii) Analysis by HPLC and MALDI-TOF. J774A.1 cells and murine peritoneal
macrophages were seeded in six-well tissue culture plates at 300,000 cells per
well, and the plates were incubated for 24 h at 37°C in 5% CO2 to allow adhesion.
The medium was replaced with fresh DMEM with peptide, and the plates were
incubated for an additional 24 h. The cells were washed three times with ice-cold
1 PBS. Cell extracts were made by lysing the cells with 100 l lysis buffer
(0.71% Nonidet P-40, 71 mM Tris, pH 7.5, 0.71 mM EDTA, 212 mM NaCl) per
well and physical scraping. Large cell debris was removed from the extract by
spinning the samples for 1 min in a microcentrifuge at 16.2 relative centrifugal
force. The samples were fractionated by reverse-phase high-performance liquid
chromatography (HPLC) and analyzed on a high-performance liquid chromato-
graph (Gold BioEssential 126/168 system; Beckman Coulter) to determine the
presence and abundance of the peptide. Samples were manually injected via a
300-l loop onto a Jupiter 4-m Proteo 90-Å column (Phenomenex, Torrance,
CA) and then eluted with 0.1% trifluoroacetic acid in 100% acetonitrile at a flow
rate of 1 ml per minute. The acetonitrile gradient was 0 to 30% from 5 to 13.5
min, 30 to 45% from 13.5 to 28.5 min, and up to 100% from 28.5 to 60 min.
Fractions were collected from 6 to 25 min at 0.2-min intervals in a UV-trans-
parent 96-well microtiter plate and were subsequently analyzed on a SpectraMax
plate reader (Molecular Devices, Sunnyvale, CA) at 280 nm (see Fig. S1A in the
supplemental material). Samples with the highest absorbances in the 17- to
19-min range (the expected elution time for the pure peptide) were suspected to
contain the peptide wrwycr, on the basis of comparisons with the chromato-
graphic profile of pure wrwycr. Matrix-assisted laser desorption ionization–time
of flight (MALDI-TOF) mass spectrometry (performed at the Scripps Center for
Mass Spectrometry, La Jolla, CA) of the HPLC fractions presumed to contain
the peptide, on the basis of the separation pattern of the pure peptide, confirmed
the identities of the wrwycr-dependent peaks, which comprised two prominent
peaks that corresponded to the expected molecular masses of the peptide mono-
mer (968 Da) and the peptide dimer (1,933 Da) (see Fig. S1B in the supple-
mental material). The monomer and dimer peaks obtained by the HPLC method
used prior to mass spectrometry were too close to be separated into different
HPLC fractions. The peptide concentrations were determined by first obtaining
the total amount of peptide in each sample by calculating the area under the
peptide peaks by using the integration function of the 32 Karat software (Beck-
man Coulter) accompanying the HPLC system and then comparing them to the
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values on a standard curve. Once the total quantity of peptide in each sample was
determined, the intracellular peptide concentration was calculated by dividing
the amount by the number of cells per sample (300,000) and the typical cell
volume of 1 pl per J774A.1 cell (13). The volume of peritoneal macrophages was
assumed to be similar.
Salmonella and wrwycr colocalization. J774A.1 cells were seeded in four-well
(LabTek-II; Fisher Scientific) chamber slides at 200,000 cells per well, and the
slides were incubated at 37°C in 5% CO2 overnight to allow adhesion. The cells
were infected with Salmonella strain SDT1416, as described above, at a multi-
plicity of infection (MOI) of 5. After 1 h of incubation with 100 g/ml gentamicin
to kill the extracellular bacteria, the cells were incubated with 50 M rhodamine-
labeled wrwycr in DMEM with 15 g/ml gentamicin for 3 h at 37°C in 5% CO2.
The peptide-containing medium was removed, and the cells were washed three
times with 1 PBS and then fixed with 4% paraformaldehyde for 10 min. After
removal of the paraformaldehyde and washing of the cells again with 1 PBS,
the chambers were detached from the slide. The slide was inverted onto a
coverslip, SlowFade reagent (Invitrogen Molecular Probes) was added to mini-
mize photobleaching, and image series were collected with a TCS SP2 confocal
microscope (Leica Microsystems Inc.).
Salmonella invasion assay. The Salmonella invasion assay was adapted from a
gentamicin protection assay (17). J774A.1 or peritoneal macrophage cells were
seeded in 24-well flat-bottom tissue culture plates at 200,000 cells per well, and
the plates were then incubated overnight at 37°C with 5% CO2. J774A.1 cells
were released from the growing surface by either physical scraping or treatment
with 1% trypsin (Invitrogen)–2 mM EDTA in 1 PBS. An overnight culture of
strain SDT1416 (100 l) was added to each well to achieve an MOI of between
1 and 2. After invasion was allowed to occur for 1 h, the Salmonella-containing
medium was removed. The cells were washed three times with 1 PBS and were
then given fresh DMEM containing 15 g/ml gentamicin. The cells were incu-
bated in the gentamicin solution for 1 h to kill the extracellular Salmonella cells.
The medium was then removed and replaced with fresh DMEM containing 15
g/ml gentamicin (to prevent residual extracellular bacterial growth) with or
without peptide. At this time (time 0 h), samples were collected and plated (see
below), while the rest of the samples were incubated for an additional 24 h at
37°C in 5% CO2. The medium was then removed and the cells were washed with
1 PBS. The cells were incubated with 500 l of 1% Triton X-100 in PBS at
room temperature for 5 min to lyse the macrophages. An additional 500 l of 1
PBS was then added to each well; and the samples were collected, diluted, plated
on LB agar plates, incubated overnight at 37°C, and counted.
Assessing Salmonella DNA damage inside macrophages. J774A.1 cells and
peritoneal macrophages were infected with Salmonella strain G785 and treated
with peptide, and the bacteria were released from the eukaryotic cells, as de-
scribed above for the invasion assay. The recovered bacteria were resuspend-
ed in 100 l 33 M 5-dodecanoylaminofluorescein di--D-galactopyranoside
(C12FDG; Invitrogen) in LB medium, and the suspension was incubated at 37°C
for 2 h. The lipophilic 12-carbon moiety of C12FDG helps the otherwise non-
membrane-permeant FDG (fluorescein di--D-galactopyranoside) to penetrate
the cell membrane. Each sample was then diluted with 500 l of 1 PBS and
analyzed on a FACSAria cell sorter (Becton Dickinson, San Jose, CA). In order
to determine the appropriate incubation time with the C12FDG substrate, 1
g/ml (final concentration) of the DNA cross-linking agent mitomycin C
(MMC), a potent inducer of the SOS response, was added to exponentially
growing Salmonella cultures for 3 h to induce DNA damage. The bacteria were
then incubated with the C12FDG substrate for various times and analyzed by flow
cytometry. In order to improve its ability to permeate the cells, the C12FDG
substrate was mixed with 0.2 mM EDTA; the EDTA by itself did not induce the
SOS response (data not shown). More than 60% of strain ATCC 14028S
(sulAp-lacZY)111 cells were positive for -galactosidase activity following the
treatment with 0.5 g/ml MMC (data not shown). By comparison, less than 1%
of the cells that either were not treated with MMC or did not carry the sulAp-
lacZ construct (G488) were positive for -galactosidase activity. In bacteria
grown in pure culture with wrwycr treatments, the fraction of Lac cells peaked
after 2 h of incubation with the C12FDG substrate and decreased to nearly 0 by
3 h, possibly due to self-quenching of the intracellular fluorescein and/or to
overwhelming DNA damage and the inhibition of transcription (data not
shown). Note that none of the wrwycr concentrations resulted in the labeling of
100% of the bacteria with fluorescein, and fewer labeled bacteria were observed
at 150 M wrwycr than at 100 M wrwycr, perhaps due to the inhibition of
transcription due to peptide-dependent damage of the template (20).
Cell viability. (i) MTT reduction assay. J774A.1 cells or peritoneal macro-
phages were seeded in 96-well plates at 40,000 cells per well, and the plates were
incubated overnight at 37°C in 5% CO2. The medium was removed and replaced
with fresh DMEM containing the appropriate treatments. The cells were treated
for 24 h. Following treatment, 20 l of a 4-mg/ml 3-(4,5-dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide (MTT) solution in 1 PBS was added to
each well. The cells were incubated with the MTT solution at 37°C in 5% CO2
for up to 3 h to allow the reduction of the MTT. One hundred microliters of lysis
buffer (20% SDS in 1:1 water-dimethyl formamide, 2% glacial acetic acid, 2% 1
M hydrochloric acid) was added to each well, and the plates were incubated at
37°C overnight to aid with dispersion of the dye. On the following day, the optical
density of the reaction mixtures was read at 575 nm with a Molecular Devices
SpectraMax Plus plate reader (Sunnyvale, CA).
(ii) Analysis by flow cytometry with Live/Dead assay kit. J774A.1 cells or
peritoneal macrophages were seeded in six-well tissue culture plates at 300,000
cells per well, and the plates were incubated at 37°C in 5% CO2 to allow
adhesion. The medium was replaced with fresh DMEM with or without peptide,
and the plates were incubated for an additional 24 h. The cells were released
from the plate by trypsinization and were then treated with the reagents in the
Live/Dead viability/cytotoxicity kit for mammalian cells (Invitrogen Molecular
Probes), according to the manufacturer’s instructions, and analyzed on a
FACSAria cell sorter (Becton Dickinson).
Statistical analysis. Statistical analysis was performed by using the SAS system
(version 9.1; SAS, Cary, NC). The Salmonella invasion results for both J774A.1
and peritoneal macrophages were log transformed to improve the normal dis-
tribution of the data. Unpaired t tests were used to assess the significance of the
differences in bacterial growth between peptide treatments. Paired t tests were
used to assess the significance of differences in the MTT assay results for both
J774A.1 cells and peritoneal macrophages. Due to the small sample sizes, the
Wilcoxon exact t test (nonparametric test) was used to assess the significance of
differences in Salmonella DNA damage and the Live/Dead assay for cell viability.
For all statistical analyses, a P value of 0.05 was considered significant. P values
are displayed only when they indicated significant differences.
RESULTS
Entry of wrwycr into macrophage and macrophage-like
cells. In order to determine whether the peptide may be effec-
tive against intracellularly growing pathogens, the ability of
Liss-Rh-labeled wrwycr to enter the host cells was initially
examined by confocal laser microscopy. Although these mod-
ified peptides are 20 times less potent at inhibiting bacterio-
phage lambda recombination (J. Boldt and A. Segall, unpub-
lished results), they were useful as tracers for localization
studies. J774A.1 cells and peritoneal macrophages were incu-
bated with rhodamine-labeled wrwycr for various lengths of
time and were then analyzed by microscopy for the assessment
of peptide uptake. The labeled peptide first became visible in
J774A.1 cells at approximately 5 min. The fluorescence in-
creased with increasing time of incubation, reaching the max-
imum intensity by 4 h (Fig. 1B to D). In contrast, Rh-labeled
wrwycr entered the peritoneal macrophages more slowly and
was visible only once it was inside these macrophages when a
10-fold higher peptide concentration was used (Fig. 1E and F).
To address the possibility that rhodamine facilitated the up-
take of the peptide, we tested and showed that the uptake of
phalloidin, which is a non-membrane-permeant mushroom
toxin that binds to filamentous actin and which is similar in size
to our peptide, is not stimulated by rhodamine (see Fig. S2A
and B in the supplemental material). However, peripheral cel-
lular staining was evident when tetramethyl rhodamine isocya-
nate (TRITC)-phalloidin was coincubated with 100 M wrwycr
(see Fig. S2D in the supplemental material), suggesting that
high peptide concentrations may affect membrane permeabil-
ity in some way. Free rhodamine, even at very high concentra-
tions (150 M), did not enter eukaryotic cells (S. Patra and
A. M. Segall, unpublished results).
The effects of temperature and inhibitors of endocytosis on
peptide uptake were tested to investigate the basic mechanism
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of uptake. Lowering of the incubation temperature from 37°C
to 4°C reduced the uptake of rhodamine-labeled peptides to
undetectable levels (Fig. 2A and B), suggesting that peptide
entry is an active process. To assess the role of endocytosis in
peptide uptake, the phosphoinositide 3-kinase (PI3K) inhibitor
wortmannin was used to prevent early endosomal vesicle fu-
sion (33). Cotreatment with 100 nM wortmannin reduced but
did not eliminate the intracellular levels of peptide, implicating
a role of endocytosis in peptide uptake (Fig. 2C and D).
To quantitatively assess peptide uptake and to circumvent
any potential effects of rhodamine on peptide uptake, an
HPLC-based method was used to directly measure the amount
of unlabeled peptide inside cells. The HPLC assay detects
peptide wrwycr on the basis of the characteristic absorbance at
280 nm by the aromatic amino acids tryptophan and, to a lesser
extent, tyrosine. Peptide wrwycr standards typically elute off
the column at about 17.5 min for the monomer and 17.75
min for the dimer (see the red trace in Fig. S1 in the supple-
mental material). Consistent with earlier observations, addi-
tion of the reducing agent dithiothreitol (DTT) abolishes the
17.75-min peak and increases the 17.5-min peak as the peptide
dimers are converted to monomers (see the blue trace in Fig.
S1 in the supplemental material). To determine the uptake of
unlabeled wrwycr, the cells were incubated with unlabeled
peptide at 37°C for 24 h. After removal of the peptide-con-
taining medium (which was also analyzed) and washing of the
cells with PBS, cell lysates were prepared and analyzed by
HPLC to determine the amount of peptide internalized. The
amount of peptide present in each sample was determined by
integrating the area under the peaks at 17.5 and 17.75 min and
comparing those to the areas on a standard curve. Intracellular
peptide concentrations were calculated by dividing the total
peptide in each sample by the number of cells per sample and
the cell volume. The average volume of a J774A.1 cell is 1 pl
(13); the typical volume of murine peritoneal macrophages was
assumed to be the same. Consistent with the microscopy data,
larger amounts of total peptide were detected in the J774A.1
cells than in peritoneal macrophages (Table 1). Less expected,
however, was the finding that the intracellular peptide concen-
trations were several hundred times higher than those in the
extracellular medium, supporting the notion that the peptide is
being concentrated within the cells. This could be due to either
active transport into cells or passive transport followed by
trapping of the peptide inside the cells and binding to cellular
constituents, preventing its equilibration with the medium. The
protocol for making cell lysates excluded membranes, and thus,
the peptide detected is intracellular rather than peptide only
peripherally or integrally associated with the membrane.
The peptide dimer-to-monomer ratios were also deter-
FIG. 1. Uptake of rhodamine-labeled peptide. J774A.1 cells were
incubated at 37°C either with no peptide (A), with 0.5 M rhodamine-
labeled wrwycr for 5 min (B), or with 1 M rhodamine-labeled wrwycr
for 4 h (C). The cells and labeled peptide were visualized by confocal
microscopy. Peritoneal macrophages were incubated for 5 h with
10 M (D) labeled peptide. The images were obtained by confocal
laser microscopy. The image shown in each panel represents an optical
slice near the center of the cell. White arrowheads indicate the nuclei.
FIG. 2. Effect of temperature or wortmannin on peptide uptake.
J774A.1 cells were incubated with 10 M rhodamine-labeled wrwycr at
either 37°C (A) or 4°C (B) for 4 h and were then visualized by confocal
microscopy. J774A.1 cells were treated with 10 M rhodamine-labeled
wrwycr for 5 h either in the presence (C) or in the absence (D) of 100
nM wortmannin and were then visualized by confocal laser micros-
copy. The image shown in each panel represents an optical slice near
the center of the cells. White arrowheads indicate the nuclei.
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mined, since the dimer species is 50 times more active in vitro
than the monomer (4). With 50 M wrwycr treatment, the
peptide dimers outnumbered the peptide monomers almost 2
to 1 in J774A.1 cells (Table 1). As the peptide treatment
concentrations increased, the ratio of intracellular peptide
dimer to monomer also increased. In contrast, the relative
abundance of peptide dimers to monomers was similar in the
50 and 100 M peptide-treated peritoneal macrophage lysates.
However, with 150 M wrwycr treatment, intracellular peptide
was predominantly in the dimeric form in both J774A.1 cells
and peritoneal macrophages (Table 1). The peptide stock so-
lution added to the medium contained at least 67% dimers (a
ratio of at least 2:1 dimer to monomer) and as much as 85%
dimers; the peptide quantified in the medium in which J774A.1
cells were treated remained in the dimeric form, while the
medium in which peritoneal macrophages were treated was
even further enriched in dimers, for unknown reasons (Table
1). The ramification of the peptide monomer and dimer dis-
tributions in the two cell types will be discussed below.
A caveat regarding the intracellular peptide concentration is
that it was calculated on the basis of the number of cells at the
beginning of the experiment, which poses a potential problem
for the analysis of J774A.1 cells. Since cell numbers were not
determined at the end of the experiment, the replication or
death of the cells was not taken into account. Under conditions
that are more conducive to cell replication (i.e., 24 h of incu-
bation at 37°C and a low peptide concentration), the calculated
intracellular peptide concentration is likely to be an overesti-
mation. At high peptide concentrations, at which cells are
more likely to die than replicate, the actual intracellular con-
centrations may have been underestimated. These caveats do
not apply to the peritoneal macrophages, since they do not
replicate in culture and are only marginally sensitive to the
peptides (discussed below).
In order to address whether the peptide is taken up actively
or passively, peptide treatment and quantitation were also un-
dertaken at 4°C, a temperature at which active transport mech-
anisms should operate poorly, if at all. In J774A.1 cells incu-
bated with 50 or 100 M peptide, there was virtually no
difference in the amount of peptide internalized by cells after
5 h at 4°C compared to the amount internalized by cells incu-
bated at 37°C. With 150 M peptide treatment, there was
about twice as much peptide present in the lysate of cells
incubated at 37°C as in the lysate of cells incubated at 4°C
(Table 2). This is in stark contrast to the microscopy results,
which showed that lowering of the incubation temperature to
4°C abolished all intracellular staining by the rhodamine-la-
beled peptides. The same trend was seen even after 24 h: cells
incubated at 4°C had at least as much intracellular peptide as
those incubated at 37°C and also had a higher proportion of
dimers than monomers (Table 2).
Salmonella and wrwycr colocalized in J774A.1 cells. To de-
termine whether the peptide penetrated the same subcellular
compartments as Salmonella, we infected J774A.1 cells with a
derivative of S. enterica serovar Typhimurium strain ATCC
14028S that constitutively expresses GFP (strain SDT1416)
and treated these infected cells with Rh-labeled wrwycr. Con-
focal microscopy revealed that there is an overlap between
GFP-expressing S. enterica serovar Typhimurium and Rh-la-
beled wrwycr inside J774A.1 cells (Fig. 3), indicating that the
peptide should be able to reach the intracellular bacteria and
exert its antibacterial effects. However, not all of the Salmo-
TABLE 1. HPLC analysis of wrwycr concentration after 24 h of incubation at 37°C
Source (peptide
concn units)b Cell type
Result for the following total input wrwycr concna:
0 M 50 M 100 M 150 M
	Pep
 D/M ratio 	Pep
 D/M ratio 	Pep
 D/M ratio 	Pep
 D/M ratio
Intracellular (mM) J774A.1 0 NAc 7.2 1.7 20.8 2.9 30.1 12.5
Intracellular (mM) Peritoneal M 0 NA 2.5 0.9 7.4 0.7 24.8 11.4
Medium (M) J774A.1 0 NA 11.6 3.8 24.7 4.1 55.4 2.5
Medium (M) Peritoneal M 0 NA 8.8 6.4 21.0 6.7 53.4 13.8
a The total peptide concentration (	Pep
) is expressed by using the molecular mass of the peptide monomer rather than that of the peptide dimer. Values are averages
of three determinations. D, peptide dimer; M, peptide monomer.
b The peptide source was either cell lysates (intracellular) or medium recovered from treated cells. Note that the intracellular concentration of peptide was in the
mM range, while the concentration recovered from the medium in which the cells were treated was in the M range.
c NA, not applicable.
TABLE 2. Effect of temperature on wrwycr uptake by J774A.1 cells
Temp (°C)
Result for the indicated input total wrwycr concn at the following time of incubationa:
5 h 24 h
50 M 100 M 150 M 50 M 100 M 150 M
	Pep
b D/M ratio 	Pep
 D/M ratio 	Pep
 D/M ratio 	Pep
 D/M ratio 	Pep
 D/M ratio 	Pep
 D/M ratio
37 0.9 2.1 8.0 2.6 28.9 11.0 1.4c 4.3 16.9 3.1 30.7 12.5
4 1.2 2.3 7.7 2.7 15.8 8.8 10.1 7.4 32.9 11.5 47.7 15.5
a The total peptide concentration is expressed by using the molecular mass of the peptide monomer rather than that of the peptide dimer. D, peptide dimer; M,
peptide monomer.
b 	Pep
, measured intracellular peptide concentration (mM).
c This concentration of peptide is unusually lower than the average for the same treatments described in Table 1.
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nella colocalized with the labeled peptide. Three categories of
localization patterns between Salmonella and the labeled pep-
tide were found. Some of the bacterial cells appeared yellow
throughout the range of focal planes spanning the entire thick-
ness of the cell, suggesting that they had taken up the labeled
peptide. Other bacterial cells appeared either yellow or green,
depending on the focal plane, and we believe that these cells
were surrounded by but did not take up the peptide. When the
focal plane was near the center of the bacterial cells, they
appeared green. When the focal plane was near the edge of the
Salmonella cells, the green fluorescence from the bacteria
overlapped with the red fluorescence from the surrounding
peptide, causing the bacteria to appear yellow. Finally, some of
the Salmonella cells appeared green in all focal planes and
presumably were not in the same compartment(s) as the pep-
tide. Approximately half of the intracellular Salmonella cells
had taken up the labeled peptide, while another third colocal-
ized with but had not taken up the peptide.
wrwycr inhibits intracellular Salmonella growth in J774A.1
cells and peritoneal macrophages. In order to test the suscep-
tibility of intracellularly growing Salmonella to peptide, J774A.1
cells were infected with S. enterica serovar Typhimurium at an
MOI of 1 for 1 h, washed, and treated with gentamicin to kill the
bacteria that did not invade the cells. The cells were then grown
in the presence or absence of peptide (and with continued gen-
tamicin treatment to prevent the residual growth of extracellular
bacteria) at concentrations near or up to 2.5-fold higher than the
MIC values determined previously (22). Initial tests confirmed
that the D-isoform peptide had a greater effect on bacterial growth
than the L-isoform peptide (data not shown), presumably due to
the resistance of the former to degradation. These preliminary
experiments also showed the antibacterial effects after 24-h pep-
tide treatments to be more pronounced than those after 12-h
treatments (a greater than 100-fold reduction in the numbers of
CFU/ml after 24 h of treatment with 100 M peptide compared
to a less than a 50-fold reduction after 12 h of treatment; data not
shown). We observed a 68.5% reduction in bacterial growth with
50 M peptide treatment and an 85.1% reduction with 100 M
peptide treatment (Fig. 4A). Since peptide wrwycr was dissolved
in dimethyl sulfoxide (DMSO), the effects of the solvent were also
tested. No statistically significant effects were observed, although
there was a trend toward a dose-dependent enhancement of bac-
terial growth. The peptide inhibited intracellular bacterial growth
in a concentration-dependent manner. Although peptide treat-
ments significantly reduced the level of Salmonella growth relative
to that in the untreated samples, they did not reduce the bacterial
numbers below those in the initial inoculum, suggesting that the
peptide is bacteriostatic rather than bactericidal inside host cells
or that the intracellular bacteria are exposed to an insufficient
amount of (active) peptide due to differential localization. Due to
cytotoxic effects (discussed below), peptide concentrations higher
than 100 M were not tested with J774A.1 cells.
J774A.1 macrophage-like cells resemble inactive macro-
phages and are very permissive for Salmonella growth. Since
wrwycr inhibited Salmonella growth inside these cells, we
tested whether wrwycr can similarly inhibit bacterial growth
inside thioglycolate-elicited murine peritoneal macrophages.
The peptide exhibited dose-dependent inhibition of bacterial
growth in the peritoneal macrophages cells as well (Fig. 4B),
although it was less potent than it was in the J774A.1 cells:
bacterial growth was reduced by only 34% and 45% with 50
M and 100 M peptide treatments, respectively. Equivalent
concentrations of DMSO did not significantly affect intracel-
lular bacterial growth. Treatment with 150 M wrwycr reduced
bacterial growth 72.3% compared to that detected in the
DMEM-treated peritoneal macrophages and by nearly 83%
compared to that achieved with the equivalent DMSO concen-
tration (1.5%). In this case, the DMSO treatment significantly
FIG. 3. Colocalization of peptide and Salmonella. J774A.1 cells were infected with GFP-expressing Salmonella (strain SDT1416) at an MOI of
5 and were then incubated with 50 M rhodamine-labeled wrwycr (red). Shown are two sets of confocal Z-series images of optical slices near the
center of the cells for two separate fields of view (A to D and E to H). Salmonella bacteria that did not colocalize with peptide appear green (black
arrowheads) in all optical slices, while those bacteria that presumably took up the peptide appear yellow (white arrowheads) in all optical slices.
Salmonella bacteria that colocalized with but that did not take up the peptide appear green in some optical slices and yellow in others (arrow).
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stimulated bacterial growth compared to the level of growth in
DMEM alone. The peptide was bacteriostatic in the peritoneal
macrophages as well as in the J774A.1 cells, as none of the
peptide treatments reduced the bacterial numbers below those
in the initial inoculum (indicated by the dotted line in Fig. 4).
Salmonella bacteria growing inside peptide-treated macro-
phages induce the SOS response. Testing of whether the
mechanism of bacterial growth inhibition by the peptide inside
macrophages was the same as the mechanism of bacterial
growth inhibition in pure culture was made more difficult by
the fact that we have been unable to isolate peptide-resistant
mutants of either Salmonella or E. coli and cannot use such
mutants to test whether they are also resistant to peptide inside
macrophage cells. Instead, we used a chromosomal SOS-in-
ducible -galactosidase reporter to determine whether the bac-
teria inside the peptide-treated cells were experiencing
DNA damage [using the SOS reporter construct present in
strain ATCC 14028S (sulAp-lacZY)111, designated strain
G785). LacZ activity was monitored by determination of the
level of production of fluorescein from the nonfluorescent sub-
strate C12FDG. Fluorescein is trapped inside cells, presumably
through the interactions of the long carbon chain with the lipid
bilayer.
To test whether intracellular bacteria accumulated DNA
damage and induced the SOS response after the host cells were
treated with peptide, we performed the invasion assay at an
MOI of 10 using strain G785. The bacteria collected from the
murine cells were incubated with C12FDG and analyzed by
flow cytometry for induction of the SOS response. The effect of
the peptide on bacterial growth was tested in parallel by taking
a small aliquot from each sample for colony count determina-
tion. Times of 4 and 24 h postinfection were used to track the
changes in both bacterial numbers and the induction of the
SOS response. At 4 h postinfection, the numbers of Salmonella
bacteria in cells grown in the absence of treatments had in-
creased by 8-fold, with only about 1% of them having induced
the SOS response (Fig. 5A and Table 3). Neither Salmonella
growth nor SOS induction was significantly affected by any of
the DMSO concentrations used (0.5%) or by treatment with 50
M wrwycr. Treatment of the macrophages with both 100 M
and 150 M wrwycr resulted in a significant increase in the
numbers of SOS-positive Salmonella bacteria and a decrease in
bacterial growth compared to the numbers of bacteria and
level of growth achieved with the DMSO treatment and, in the
case of the higher peptide concentration, compared to the
numbers of bacteria and level of growth achieved with
DMEM-treated cells as well.
By 24 h postinfection, the numbers of intracellular Salmo-
nella bacteria in J774A.1 cells grown in the absence of peptide
treatments had increased by over 240-fold, a more than 30-fold
increase since the 4-h time point (Fig. 5B). On average, only
0.6% of these bacteria were positive for an SOS response
(Table 3). Treatments with 100 M and 150 M peptide in-
hibited intracellular Salmonella growth by at least 99% (Fig.
5B) and resulted in significantly higher fractions of SOS-posi-
tive Salmonella bacteria (Table 3). However, despite the99%
decrease in growth, the peptide treatments did not reduce the
bacterial levels much below those in the initial inoculum, which
is indicated by the dotted line in Fig. 5.
wrwycr toxicity toward J774A.1 cells and peritoneal macro-
phages. To determine whether the peptide effects are directly
on the bacteria or are indirect due to their toxicity to the host
cells, we assessed their effects on eukaryotic cells using the
MTT metabolic assay, in which the yellow compound MTT is
reduced to a purple formazan derivative by lactate and succi-
nate dehydrogenases (29). Compared to treatment with
DMEM, treatment with 50 M wrwycr did not reduce the
metabolic activity of J774A.1 cells (Fig. 6A). Surprisingly, 0.5%
FIG. 4. Effects of wrwycr (also known as d8) on intracellular Salmonella growth. J774A.1 cells (A) and peritoneal macrophages (B) were
infected with S. enterica serovar Typhimurium ATCC 14028S at an MOI of 1 and were then incubated with wrwycr at the indicated concentration
for 24 h. Gentamicin (15 g/ml) was included in the peptide treatments to prevent extracellular bacterial growth, which ensured that the effects
of the peptide observed were due to the inhibition of intracellular Salmonella growth. The effects of DMSO and the peptide were normalized to
the effects on the DMEM-treated controls. The inoculum at time zero is indicated by the horizontal dashed line. Shown are the average levels of
bacterial growth inhibition and standard errors. *, statistical significance with P  0.05; **, statistical significance with P  0.005.
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DMSO treatment resulted in a borderline-significant increase
in the MTT signal of nearly 29%. While 100 M wrwycr treat-
ment resulted in a 17.3% decrease in the metabolic activity of
J774A.1 cells compared to that achieved with DMEM treat-
ment, the same effect was observed with treatment 1% DMSO,
the amount of peptide solvent present in 100 M wrwycr. The
peritoneal macrophages were much less sensitive to the pep-
tide. Up to 100 M wrwycr and 1.5% DMSO had no significant
effect on the metabolic activity of the peritoneal macrophages
(Fig. 6B). Treatment with 150 M wrwycr, however, resulted in
a significant increase (18%) in the metabolic activity of the
peritoneal macrophages (Fig. 6B).
While the MTT reduction assay showed that wrwycr at 100
M has detrimental effects on the overall metabolic activity of
J774A.1 cells, the assay cannot distinguish between the possi-
bility that 17% of the cells died and were therefore metaboli-
cally inactive while the rest were normal or there was an av-
erage of a 17% decrease in the metabolic activity of all cells.
Therefore, we tested the viability of individual peritoneal mac-
rophages and J774A.1 cells using a fluorescence-based viabil-
ity/cytotoxicity assay and analyzed individual cells by flow cy-
tometry. This assay discriminates between live and dead cells
on the basis of both the integrity of the membrane (penetration
of the membrane-impermeant ethidium homodimer) and the
enzymatic activity of esterases that cleave the nonfluorescent
membrane-permeant calcein acetoxymethyl ester (calcein AM)
to produce the green fluorescent molecule calcein. Dead cells
are permeable to the ethidium homodimer and lack active
esterases (e.g., Fig. 6C). Cells that were positive for both cal-
cein and the ethidium homodimer were in the early stages of
death, on the basis of the observation that they did not recover
when they were sorted and replated in peptide-free medium
(data not shown). The Live/Dead assay reported that 35% of
the J774A.1 cells died as a result of 100 M wrwycr treatment,
an effect greater than that which we saw by the MTT reduction
assay (Table 4). Peritoneal macrophages were less sensitive to
FIG. 5. Induction of the SOS response upon wrwycr (also known as d8) treatment in intracellular bacteria. J774A.1 cells were infected with
G785 (carrying an SOS reporter gene fusion) at an MOI of 10 and incubated with the indicated treatments for 4 or 24 h. Gentamicin (15 g/ml)
was included to prevent extracellular bacterial growth. The colony counts of intracellular Salmonella from J774A.1 cells were determined at 4 h
(A) and 24 h (B) postinfection. The inoculum at time zero is indicated by the horizontal dashed line. Each data point shown represents the colony
counts from a single well, and the means are indicated by the horizontal bars. The P values shown are the results of Wilcoxon exact one-tailed t
tests. Statistical analysis was performed on all pairwise combinations, but only significant (or nearly significant) differences are shown. *, statistical
significance with P  0.05; **, statistical significance with P  0.005; hpi, hours postinfection.
TABLE 3. Fraction of Salmonella bacteria inside J774A.1 cells in
which the SOS response was induced at 4 h and
24 h postinfection
Treatment
4 h postinfection 24 h postinfection
%
bacteriaa
% SOS
cellsb % bacteria
% SOS
cells
DMEM 66.7  4.4 1.4  1.3 74.3  1.7  0.01
0.6% DMSO 80.2  3.5 0.3  0.2 57.8  08  0.01
50 M wrwycr 57.1  5.8 0.3  0.1 45.2  10.2 0.4  0.2
1.2% DMSO 76.1  4.0 0.1  0 57.1  13.3 0.03  0.1
100 M wrwycr 19.0  1.7 1.3  0.6 2.8  0.5 16.5  4.8
1.8% DMSO 82.5  3.7 0.1  0.1 54.2  9.8  0.01
150 M wrwycr 3.0  0.9 8.5  3.1 1.9  0.2 28.4  5.2
a % bacteria, the fraction of Salmonella bacteria, determined by reactivity with
LPS antibody, among the number of particles released by lysis of J774A.1 cells
that fit the forward-scatter versus side-scatter parameters characteristic of bac-
terial cells. The other particles may be mitochondria and/or other nonbacterial
particles.
b % SOS cells, the fraction of fluorescein-positive Salmonella bacteria (LPS-
positive particles). All the differences between the percentage of SOS response-
positive cells in 1.2% DMSO versus the percentage obtained after treatment with
100 M peptide and in 1.8% DMSO versus the percentage obtained after
treatment with 150 M peptide at either 4 h or 24 h are significant (P values of
0.0022 in all cases, in Wilcoxon exact one-tailed t tests).
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the peptide, just as the MTT reduction assay indicated, with
only 10% cell death achieved with 150 M wrwycr (Table 4).
DISCUSSION
In order to investigate its potential as an antibiotic, we ex-
amined the ability of peptide wrwycr to enter murine macro-
phage cells and to affect the growth of the bacterial pathogen
Salmonella Typhimurium, in addition to examining the pep-
tide’s cytotoxicity toward the host cells.
Peptide wrwycr readily entered J774A.1 murine macro-
phage-like cells at low micromolar concentrations within min-
utes. In contrast, entry into peritoneal macrophages was much
less efficient: a concentration of rhodamine-labeled peptide up
to 10-fold higher was needed to see intracellular staining. The
uptake of the labeled peptide by J774A.1 cells was greatly
reduced, but not eliminated, by the endocytosis inhibitor wort-
mannin. It is possible that the peptides also entered cells by
increasing the permeability of the plasma membrane by using
mechanisms similar to those of other cationic antimicrobial
peptides, such as melittin (5, 7, 27, 35, 37); however, wrwycr
has no predicted alpha helix-forming propensity, like melittin
and other pore-forming antimicrobial peptides. The amino
acid composition of peptide wrwycr chemically resembles the
cell-penetrating class of peptides (CPPs) that are derived from
a number of eukaryotic proteins, including HIV-1 Tat and the
Drosophila Antennapedia homeodomain-derived penetratin
peptide Antp (39). These peptides are noted for their amphi-
pathic nature and their positive charge at physiological pH
(they are composed of from 17 to 100% positively charged
amino acids [39]). CPPs use both endocytotic mechanisms and
temperature- and endocytosis-independent membrane translo-
cation and require endosomal acidification for efficient entry
into the cytoplasm (16, 20, 24, 34, 35). In the case of peptide
wrwycr, HPLC analysis revealed intracellular concentrations
several hundred times higher than the input concentrations,
even at 4°C; this temperature-independent uptake is similar to
that of CPPs. In contrast, the rhodamine-labeled peptide did
not enter cells at 4°C, and its entry may depend on endo-
cytosis rather than direct translocation for its entry. Trypan
blue dye exclusion showed that cell membrane integrity was
not compromised during the extended incubation at 4°C and
FIG. 6. Effects of wrwycr (also known as d8) on host cell viability.
MTT reduction assay results for J774A.1 cells (A) and peritoneal
macrophages (B) are shown. Cells were grown in 96-well plates and
treated with wrwycr and DMSO at the indicated concentrations for
24 h. Following treatment, the cells were allowed up to 3 h to convert
MTT to formazan, as measured by determination of the optical density
at 575 nm. Shown are the average effects of the treatments on MTT
reduction with standard errors normalized to the results for the un-
treated (DMEM-treated) control. The means are indicated by the
short horizontal bars. The P values shown are the results of Wilcoxon
one-tailed tests. Statistical analysis was performed on all pairwise com-
binations, but only significant (or nearly significant) differences are
shown. *, statistical significance with P  0.05; **, statistical signifi-
cance with P  0.005. (C) Sample dot plots from flow cytometric
analysis of effects of wrwycr on J774A.1 cell viability by the Live/Dead
assay. (Top left quadrant) Cells not stained with the Live/Dead stain
do not autofluoresce; (top right quadrant) live cells (untreated) appear
green on the basis of their ability to generate calcein from calcein AM
and to exclude the ethidium homodimer; (bottom left quadrant) dead
cells (killed with methanol for 5 min for 37°C) were unable to process
calcein AM and stain red with the ethidium homodimer; (bottom right
quadrant) J774A.1 cells treated with wrwycr for 24 h stain green or red
or double stain both red and green. The cells that were positive for
both calcein and the ethidium homodimer were in the earlier stages of
death; they were not able to recover when they were replated in
peptide-free medium. The results for the complete treatment sets are
shown in Table 4.
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thus does not account for peptide uptake at this temperature
(data not shown). It is also possible that the peptide is effluxed
to a greater extent at 37°C than at 4°C. More detailed analyses
of the mechanisms of peptide transport, efflux, and subcellular
localization, including how the peptide colocalizes with Salmo-
nella, are future goals.
Fifty, 100, and 150 nmol of peptide are present in 1 ml of the
50, 100, and 150 M peptide treatments, respectively. Typi-
cally, the amount of total peptide recovered (in the lysate and
spent medium) at the end of the 24 h of incubation at 37°C
ranged from 7 to 65 nmol, accounting for approximately 14 to
43% of the total peptide added. The rest of the peptide was
most likely bound to membranes or was sequestered in various
vesicles and lost in the cell debris pellet. Because the peptides
used are composed of D-conformation amino acids, degrada-
tion of the peptide backbone should not occur, but it is possible
that some degradation of the side chains may account for some
of the peptide loss.
Peptide effect on Salmonella growth inside murine macro-
phages. Peptide wrwycr exhibited dose-dependent inhibition of
Salmonella growth in both J774A.1 cells and peritoneal mac-
rophages. The inhibitory effect in J774A.1 cells was dependent
on the MOI of the bacterial infection: the reduction in bacte-
rial colony counts observed with 100 M wrwycr, for example,
was almost 10-fold greater when the Salmonella MOI used was
10 (Fig. 5B) than when the MOI was 1 (Fig. 4A). Thus, the
peptide concentration per bacterial cell is not limiting inside
the macrophages. We do not know why the MOI should affect
the efficiency of the peptide. One possibility is that at greater
MOIs, the physiological state of the intracellular Salmonella
bacteria makes them more susceptible to killing by our pep-
tide, while another is that the Salmonella bacteria stimulate the
host cell response in a manner that increases peptide-depen-
dent killing. Certainly, higher Salmonella multiplicities of in-
fection have been shown to cause more cytotoxicity in mam-
malian macrophages and macrophage-like cells (31). This
observation predicts that we would observe greater peptide-
dependent killing in peritoneal macrophages as well (in which
infection was done only at an MOI of 1), and this will be tested
in the future.
Because the intracellular peptide concentration is at least 20
times the in vitro bactericidal concentration, it is possible that
much of the intracellular peptide is not available to the Sal-
monella bacteria. Alternatively (and not mutually exclusively),
Salmonella bacteria growing intracellularly may be more resis-
tant to the peptide than those grown in pure culture, perhaps
due to membrane modifications that interfere with the pep-
tide’s uptake by bacterial cells. In order to reach the Salmo-
nella cells, either the peptide must enter Salmonella-containing
vesicles from the cytoplasm or peptide-containing endosomes
must fuse with Salmonella-containing vesicles, perhaps limiting
the access of the peptide to the bacteria. Confocal microscopy
with the rhodamine-labeled peptide indicated that 50% of
the bacteria had taken up the peptide inside J774A.1 cells and
another 30% were in close proximity to it, leaving open the
possibility that some intracellular bacteria either were not ex-
posed to the peptide or were exposed to levels too low to elicit
the bactericidal effects seen in free-growing bacterial cells.
The potency of peptide wrwycr against Salmonella growing
inside murine peritoneal macrophages was somewhat less than
that of Salmonella growing in J774A.1 cells. The peptide en-
tered peritoneal macrophages less efficiently than it did
J774A.1 cells: twice as much peptide was required to achieve
the same intracellular concentration in peritoneal macro-
phages that was present in J774A.1 cells when the peptide
input concentration was 50 M, and only at the highest con-
centration (150 M) did the peptide dimer concentrations
exceed the peptide monomer concentrations. However, when
the bacterial growth inhibition effects were normalized to the
intracellular peptide concentration, peptide wrwycr was indeed
more potent against Salmonella growth in peritoneal macro-
phages than in J774A.1 cells. We expected the greater oxida-
tive response elicited by Salmonella in peritoneal macrophages
(11) to cause more bacterial DNA damage, leading to an
increased concentration of DNA repair intermediates and,
thus, more targets for the peptide (22). In pure culture, hydro-
gen peroxide and the peptide synergistically kill E. coli in
culture (Y. Xu and A. Segall, unpublished results).
Inferring DNA damage from the bacterial SOS response. To
test whether the peptide’s mechanism of Salmonella growth
inhibition inside tissue culture cells is the same as that in pure
culture, we used a Salmonella strain carrying the lacZ gene
driven by the sulA promoter, a reporter for the SOS response.
When LacZ activity specifically among LPS-positive particles
was monitored by flow cytometry, a dose-dependent induction
of the SOS response was detected in the bacteria isolated from
peptide-treated J774A.1 cells but not in bacteria isolated from
DMEM- or DMSO-treated J774A.1 cells. This is consistent
with the proposed mechanism of peptide killing in pure cul-
ture, namely, interference with DNA repair and the accumu-
lation of unrepaired DNA damage (22). In pure culture, only
about a 4-fold induction of the SOS response in the whole
population was detected by use of the reporter genes; flow
cytometry for detection of the induction of the SOS response
on an individual-cell basis also showed that the SOS response
was induced in only a fraction of the population (Table 3 and
data not shown; Y. Xu, I. Naili, and A. Segall, unpublished
results). It is possible that the peptide has multiple targets in
bacteria and that only some cells die of unrepaired DNA dam-
age and induce the SOS response. Alternatively, it is possible
that at high peptide concentrations, all the bacteria in pure
TABLE 4. Effect of wrwycr on viability of J774A.1 cells and
peritoneal macrophages determined by the Live/Dead assay
Treatment
% cells
J774A.1 Peritoneal macrophages
Livea Deadb Live Dead
DMEM 95.6  1.9 1.7  1.1 94.1  1.9 4.3  1.0
0.5% DMSO NTc NT 94.8  0.5 3.2  0.2
50 M wrwycr 93.0  0.4 4.3  0.7 94.2  0.9 3.2  1.0
1.0% DMSO NT NT 93.9  0.6 3.5  0.9
100 M wrwycr 58.9  11.1 35.3  10.3 94.4  0.7 3.1  0.3
1.5% DMSO NT NT 94.9  1.1 3.3  1.0
150 M wrwycr NT NT 87.9  7.0 9.2  7.9
a Live, cells that processed calcein AM to calcein in the Live/Dead assay by the
use of cellular esterases.
b Dead, the fraction of cells that are permeable to propidium iodide, indicating
membrane disruption.
c NT, not tested.
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culture or grown intracellularly die of unrepaired DNA dam-
age but that a high proportion of these sustain so much damage
that transcription of the SOS reporter is inhibited. A third
possibility is that some of the DNA damage caused by the
peptide does not induce the SOS response (alkylation damage,
for example, does not induce the SOS response).
The fact that bacteria grown in DMEM- or DMSO-treated
J774A.1 cells did not induce the SOS response under parallel
conditions is consistent with the low oxidative burst of these
cells in the absence of added gamma interferon (-IFN), but a
microarray-based study by Hinton and colleagues of gene ex-
pression in Salmonella enterica growing inside macrophages
identified a number of moderately induced SOS genes (3- to
5-fold greater expression relative to that of the control at 4 h or
12 h), including lexA, dinF, uvrB, recN, and dinB (18). However,
most members of the SOS regulon were not similarly induced,
for example, the uvrA and uvrC genes (0.95 to 1.24-fold induc-
tion at 4 h or 12 h). Notably, the sulA gene, assayed in our
study, was induced only 1.6-fold relative to that for the control
at 4 h and 2-fold at 12 h (12 h was the latest time point
evaluated in the study of Hinton and colleagues [18]); this
subtle level of induction may not be easily detectable in our
assay. The greatest level of SOS gene induction in the study of
Hinton and colleagues was observed at 8 h (and was as much
as 30% greater than that at 4 or 12 h), followed by decreased
gene expression at 12 h; by 24 h, the time point at which we saw
the greatest sulA induction, the Salmonella bacteria inside un-
treated macrophages may have repaired the DNA damage that
caused the increase in the level of expression of the SOS
response gene, and the induction of sulA in the peptide-treated
bacteria was most reasonably due to persistent damage that
was not or that could not be repaired. Another technical dif-
ference between the microarray study and our own was the
very large MOI used by Hinton and colleagues (100 Salmonella
per macrophage infected), which may also have contributed to
the differences between our observed lack of induction in un-
treated bacterial cells compared to the results of the study of
Hinton and colleagues (18); as discussed above, the greater
bacterial load may cause a much greater response on the part
of the host cells. Finally, the greater oxidative burst of the
peritoneal macrophages would be expected to induce the SOS
response even in bacteria not treated with peptide, thereby
hiding the peptide effect. Preliminary experiments that used
IFN- to stimulate J774A.1 cells and a Salmonella MOI of 1
showed that the stimulated macrophage-like cells killed the
bacteria to similar levels with or without the peptide. However,
those experiments will be repeated in the future with a larger
Salmonella MOI, at which we saw greater killing by the pep-
tide.
The toxicity of the peptide for the murine cells was assessed
by the population-based MTT reduction assay, which measures
metabolic activity, and a flow cytometry-based viability assay.
Together, those assays showed that the J774A.1 cells (a trans-
formed cell line) were more sensitive to the peptide than the
primary peritoneal macrophages. Even with treatment with
150 M peptide, over 90% of the peritoneal macrophages
remained viable. In contrast to the MTT data, 50 M peptide
treatment did not cause increased J774A.1 cell death, as de-
termined by the Live/Dead assay. This suggests that low con-
centrations of wrwycr may reduce cell metabolic activity rather
than cause death. Even with 100 M peptide treatment, there
was virtually no increase in the proportion of dead cells; how-
ever, at this peptide concentration, up to 40% of the J774A.1
cells, in some cases, had become positive for staining with both
the live and the dead stains (a representative dot plot is shown
in Fig. 6C). The inability of these cells, after they were sorted,
to even adhere to the plates, much less replicate, indicated that
they were nonviable cells that retained residual enzymatic ac-
tivities. On the basis of these results, these cells were catego-
rized as “dead” cells in Table 4. In aggregate, these results
indicate that peritoneal macrophages are much more resistant
to peptide treatment than J774A.1 cells. This result is consis-
tent with the results of other studies in which we have found
that primary or slowly dividing cells, for example, mouse car-
diac myocytes or low-passage-number cells of the IMR-90 cell
line, are quite resistant to the peptide, while relatively fast-
dividing cell lines, such as HeLa and U2OS cells, are much
more susceptible (L. Su, S. Patra, and A. Segall, unpublished
data; S. Patra, R. N. Authement, and A. Segall, unpublished
data).
Although the rhodamine-labeled peptides localized primar-
ily in the cytoplasm, nuclear staining was apparent at 4 h and
later time points, albeit at reduced levels compared to the level
of cytoplasmic staining. Nuclear entry and interference with
the repair of endogenous DNA damage may be one of the
major mechanisms of peptide wrwycr toxicity in mammalian
cells (Su et al., unpublished; Patra et al., unpublished). Slower
and reduced levels of entry into the nucleus may spare the host
cells from the peptide’s predominant toxic effects, supported
by the greater toxicity of peptides to which nine N-terminal
arginines (R9), a CPP tag which promotes the permeation of
cargo proteins in mammalian cells (21), were added. These
R9-tagged peptides entered cells and concentrated in the nu-
cleus extremely efficiently and were much more toxic than the
unmodified peptides (L. Su, D. Fujimoto, and A. Segall, un-
published data). Reducing the nuclear permeability without
decreasing the binding activities toward branched DNA repair
intermediates should decrease the toxicities of these antibiotics
and enhance their usefulness.
The activity of peptide wrwycr at killing intra- and extracel-
lular bacteria is a promising proof of principle for this inhibitor
that binds to intermediates of DNA repair, a novel target for
antibiotics. The peptide binds to branched DNA molecules,
with the peptide having the highest affinities for Holliday junc-
tions and somewhat lower levels of affinity for complete or
partial replication forks (those that have only the leading or
the lagging strand) (25, 26). Such structures are expected to
arise when replication forks regress or when they collapse
when they encounter double-strand breaks or nicks; covalent
protein-DNA intermediates, such as those that occur during
abortive topoisomerase reactions; and interstrand cross-links,
among others (14, 15, 28). Branched DNA structures arise in
several independent ways, making it difficult to prevent their
occurrence without rendering the cell extremely debilitated.
Even if they arise, bacterial mutants defective in DNA repair
would very likely be hypersensitive to killing by the immune
system. Moreover, the peptide does not appear to depend on
any single uptake system for transport, since neither deletions
of the major peptide uptake system in B. subtilis nor deletion of
any single nonessential E. coli gene present in the Keio knock-
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out collection (2) confers resistance to the peptide (22; S.
Orchard and A. Segall, unpublished results). No spontaneous
mutants have been isolated in a hyperpermeable Salmonella
strain with short LPS chains (1) (the maximum sensitivity of
the assay was 1 in 1010 [J. Patelzick and A. Segall, unpublished
results]). In aggregate, these properties suggest that the pep-
tide may be a very effective antibiotic from the standpoint of
the low-frequency evolution of resistance-conferring muta-
tions. A possible disadvantage of the peptide’s targets is that
DNA repair intermediates in bacteria may be similar enough
to those in the mammalian host to cause toxic side effects.
However, as discussed above, inefficient nuclear transport and
the chromatin structure itself may protect eukaryotic host cells.
These features may be improved upon when future genera-
tions of these antimicrobial compounds are designed in order
to increase the differential toxicities between bacteria and
mammalian cells.
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